Coronavirus Update: 891,483 Infections, 23,687 Related Deaths; ‘Delta’ Variant Spreading Mostly Among Kids, Could Become Dominant Strain in US


The B.1.617.2 variant, which originated in India is 40 to 60 percent more transmissible than other variants seen in the state, and accounts for more than 7 percent of all cases sequenced in the past four weeks.

By Matt Skoufalos | June 21, 2021

COVID-19 Dashboard – 6-21-21. Credit: NJDOH.

Another 126 New Jersey residents have tested positive for novel coronavirus (COVID-19), bringing the statewide total to 891,483 cases confirmed via polymerase chain reaction (PCR) testing, Governor Phil Murphy reported Monday.

New Jersey is also reporting 42 new COVID-probable cases based on antigen tests, bringing the statewide total to 129,825 positive antigen tests.

Antigen tests have a faster turnaround time than PCR tests—sometime within 15 to 30 minutes—but are less reliable at detecting active infection of the virus, and more capable of reporting false positives.

Sadly, three more residents have perished from complications related to the virus, bringing the statewide, confirmed death toll to 23,687 lives lost during the pandemic.

In addition to those lab-confirmed fatalities, the state has acknowledged another 2,690 probable COVID-19-related deaths.

Since March 2020, 979 of every 100,000 New Jersey residents have been hospitalized with COVID-19, and 269 of every 100,000 have died from COVID-19-related complications.

More than 14.398 million polymerase chain reaction (PCR) tests for COVID-19 have been performed statewide, with a 10.138-percent positivity rate per 100,000 residents.

Rate of transmission (Rt) at 0.99

The statewide average of COVID-19 spot positivity testing based on PCR test results stood at 0.95 percent June 20.

Rt, the variable that describes the seven-day, rolling-average, statewide rate of transmission of new COVID-19 cases, hit 0.99 on June 21.

Any Rt figure less than 1.0 means that each new COVID-19 patient is infecting fewer than one other person, on average, and the spread of the virus is decreasing.

Since its mid-April-2020 COVID-19 spike, the highest reported RT in New Jersey was 1.48, recorded August 1, 2020. Prior to artificially low, adjusted reports of 0.34 in the first week of May, the lowest in the past year was 0.62, recorded June 9, 2020. On May 21, 2021, it reached a new low, of 0.59.

Simulated COVID-19 patient in a hospital bed. Photo by Mufid Majnun on Unsplash

Hospitalizations continue sustained decline

Throughout New Jersey, 305 people currently are hospitalized with a suspected (72) or confirmed (233) case of COVID-19, Murphy said.

Among those hospitalized patients, 79 are in intensive or critical care, and 46 of the ICU and critical-care patients (58 percent) are on ventilators.

In New Jersey’s 71 critical care hospitals, 33 patients were hospitalized with COVID-19 yesterday, while 27 others were discharged.

LTC update

Across the state, long-term care (LTC) centers have reported 1,476 cumulative outbreaks of COVID-19, and 38 are dealing with an active outbreak. LTCs account for 54,987 infected patients and staff in New Jersey, or 6.2 percent of total cases.

That includes 32,774 residents and 22,213 staffers sickened by the virus, as well as 8,060 lab-confirmed resident and staff deaths (34 percent of the statewide confirmed total), with facilities self-reporting 144 staff deaths.

Of 623 veterans residing in three state-run homes, 456 residents have tested positive for COVID-19, and 156 have died from complications related to the virus. Three hundred veterans have recovered from the virus. One resident is currently COVID-19-positive.

The facilities at Menlo Park, Paramus, and Vineland are staffed by 1,335 workers, one of whom is presently COVID-19-positive. The facilities have sustained two staff deaths related to the virus.

At state-run psychiatric facilities, 367 of 1,128 patients and 1,077 staff members have tested positive for COVID-19. Fourteen patients and eight staffers have died from complications related to the virus.

MISC cases and schools

To date, 127 New Jersey children aged 1 to 18 have been diagnosed with pediatric multisystem inflammatory syndrome (MISC). Four of those cases were reported in Camden County, tied with Cumberland and Monmouth Counties for third-least in the state.

All those pediatric patients have tested positive for an active COVID-19 infection or the presence of COVID-19 antibodies, indicating exposure to the virus. No deaths have been associated with this syndrome in New Jersey, although several children have been hospitalized during their treatment for the illness.

Since August 1, 2020, 281 COVID-19 outbreaks encompassing 1,263 individual cases have been traced to schools in all 21 New Jersey counties. In Camden County, 18 outbreaks have been linked to 78 cases, sixth-most in the state.

COVID-19 vaccine bottle mock-up. Photo by Daniel Schludi on Unsplash

Vaccination update: NJ surpasses 4.8M fully vaccinated people, 9.4M doses administered

Across New Jersey, 9.435 million COVID-19 inoculations have been administered.

Throughout New Jersey, 4.553 people have been fully vaccinated in-state, having received either a one-shot formulation from Johnson and Johnson or both doses of the two-shot Pfizer or Moderna vaccines.

In Camden County, 514,741 doses have been administered; seventh-most in the state.

An estimated 565,742 New Jersey residents have received a vaccine dose outside of the state, of which 248,347 are estimated to have been fully vaccinated.

The first vaccines in the state were administered December 15, 2020; by February 8—55 days later—New Jersey had immunized its millionth resident. Twenty days thereafter, that count hit 2 million, and 3 million within two more weeks.

On March 29, New Jersey crossed the 4-million-dose threshold, and the state cleared 5 million doses over the weekend of April 10, 2021. Eight days after that, New Jersey hit the 6-million-dose mark. By May 3, 2021, the state had cleared 7 million doses administered, and two weeks later, it had surpassed 8 million doses.

As of June 2, 2021, the state had cleared 9 million administered doses and 4 million fully vaccinated New Jerseyans, and on June 18, hit 4.7 million vaccinated individuals, its target goal for 70 percent of the adult population of the state.

According to New Jersey Health Commissioner Judy Persichilli, the percentage of New Jerseyans who have received at least one vaccine dose varies by age, with the oldest residents accounting for the bulk of inoculations:

  • 88 percent of those 65 and older have received at least one vaccine dose, and 80 percent of them are fully vaccinated
  • 76 percent of those aged 50 to 64 have received at least one dose
  • 63 percent of those aged 30 to 49 have received at least one dose
  • 53 percent of those aged 18 to 29 have received at least one dose
  • 39 percent of those aged 16 to 17 have received at least one dose
  • 33 percent of those aged 12 to 15 have received at least one dose


“Fully vaccinated people are much safer to engage in everyday life than unvaccinated people,” Murphy said, encouraging residents to “get vaccinated as soon as possible.”

Last week, he added that “there is only a pandemic among those who have yet to get their shot.”

“We won’t stop until we get to 70 percent in every county and every municipality,” Persichili said Monday.

NJ Health Commissioner Judy Persichilli – 6-21-21. Credit: NJ Pen.

B.1.617.2 ‘Delta’ variant spread predominantly by children

Mutated offshoots of COVID-19, or “variants of concern,” continue to circulate throughout New Jersey; the state has traced thousands of such cases to date.

Persichilli noted last week that the U.S. Centers for Disease Control (CDC) has now upgraded the status of the B.1.617.2 “Delta” variant from a “variant of interest” to a “variant of concern.”

Initially identified in India in December 2020, B.1.617.2 has been detected in 66 countries, including in the United States.

It currently accounts for 7.3 percent of the variants sequenced in New Jersey in the past four weeks (up from 5.1 percent last week), and is believed to be 40 to 60 percent more transmissible than other strains of the virus.

Accounting for 10 percent of new cases in the United States, the delta variant could become the dominant strain in the country within the next month, and is believed to be spread by “children and young people,” Persichilli said.

“The spread of this variant is another reason for us to remain vigilant to continue to strive to increase vaccine rates,” she said.

Presently, the most common COVID-19 variant in the United States is the B.1.1.7, or “alpha” variant, which was first identified in the United Kingdom, and has been detected in all 21 New Jersey counties.

B.1.1.7 has been associated with a 50-percent increase in COVID-19 transmission over earlier strains of the virus detected in New Jersey, and likely increased severity of infection based on hospitalization and case fatality rates.

Strain B.1.526, which originated in New York state, represents 16 percent of the variants identified in New Jersey in the past month, and is a “variant of interest,” Persichilli said.

The P.1 “Brazilian” variant accounts for 3.5 percent of the variants identified in the past month, and B.1.617.2, which originated in India, accounted for 3.1 percent of all specimens sequenced in the past five weeks.

Smaller percentages of the California variants B.1.427 and B.1.429 also were reported in the data, the health commissioner said.

Roughly 2 percent of positive samples are being tested for variants, Dr. Ed Lifshitz, head of the New Jersey communicable disease service, has said.

Read our ongoing round-up of COVID-19 coverage here.

Please support NJ Pen with a subscription. Get e-mails, follow us on FacebookTwitter, and Instagram, or try our Direct Dispatch text alerts.


Comments are closed.